Hypometabolism in Healthy Brains May Indicate Pre-Alzheimer’s

Article

PET finds hypometabolism in healthy brains that may indicate pre-Alzheimer’s disease.

PET images detected an association between hypometabolism and amyloid in brains of people with pre-Alzheimer’s who don’t show any signs of cognitive decline, according to presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2013 annual meeting.

The amyloid plaque build-up in the brain in Alzheimer’s is known, but now there appears to be a connection between the amyloid burden and hypometabolism of neurons in parts of the brain that have been associated with Alzheimer’s disease.

“Previous studies indicate that hypometabolism of this same pattern is present in people who have abnormalities of the gene apolipoprotein E, or APOE,” Val J. Lowe, MD, professor of radiology at Mayo Clinic Cancer Center, said in a release. “Hypometabolism does appear to be an early harbinger of the disease before dementia sets in.”.

Researchers from the Mayo Clinic Study of Aging studied PET images of 617 cognitively normal subjects. Each subject first underwent imaging with the amyloid-binding radionuclide imaging agent C-11 Pittsburgh compound B (PiB), followed an hour later with a second exam which used F018 fluorodeoxyglucose (FDG).

The researchers found that there was significant hypometabolism in brain regions classically associated with Alzheimer’s disease, including the angular gyrus and posterior cingulate.

The researchers will continue to follow the subjects to see if they progress to Alzheimer’s disease, and to study the ones do not develop the disease but do have amyloid in their brain.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Emerging Innovations in Molecular Imaging
Related Content
© 2025 MJH Life Sciences

All rights reserved.